2026 Celia A. Schiffer: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	80	4129	3808	2026	1826	445	21051

Overview

Celia A. Schiffer is affiliated with the University of Massachusetts Chan Medical School in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant focus on Molecular Biology, Infectious Diseases, Virology, Computational Theory and Mathematics, and Epidemiology.

The scientist's research topics cover a broad range within biomedical sciences and infectious diseases, including:

HIV/AIDS drug development and treatment
SARS-CoV-2 and COVID-19 research
HIV research and treatment
Computational drug discovery methods
RNA and protein synthesis mechanisms
Hepatitis C virus research
Monoclonal and polyclonal antibodies research

Among their recent papers are the following:

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations, 2021, Immunity
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction, 2020, Nature Communications
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms, 2022, eLife
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance, 2022, Nature Communications
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188, 2021, Viruses

The frequent co-authors associated with Celia A. Schiffer's work include:

Neşe Kurt Yılmaz
Ala M. Shaqra
Akbar Ali
Qiu Yu J. Huang
G.J. Lockbaum

Publications are often found in venues such as:

bioRxiv (Cold Spring Harbor Laboratory)
UNC Libraries
Nature Communications
Journal of Biological Chemistry
Viruses

Best Publications

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

Mayer Rj;Davis Rb;Schiffer Ca;Berg Dt

2083
Citations
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.

Moses Prabu-Jeyabalan;Ellen A. Nalivaika;Celia A. Schiffer

419
Citations
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

R. M. Stone;T. Fischer;R. Paquette;G. Schiller

351
Citations
Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes.

Silverman Lr;Holland Jf;Weinberg Rs;Alter Bp

317
Citations
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.

Dominique L. N. G. S Surleraux;Abdellah Tahri;Wim G. Verschueren;Geert M. E. Pille

310
Citations
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

J C Byrd;R B Weiss;D C Arthur;D Lawrence

306
Citations
Structural and Thermodynamic Basis for the Binding of TMC114, a Next-Generation Human Immunodeficiency Virus Type 1 Protease Inhibitor

Nancy M. King;Moses Prabu-Jeyabalan;Ellen A. Nalivaika;Piet B. T. P. Wigerinck

301
Citations
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Thomas D. Wu;Celia A. Schiffer;Matthew J. Gonzales;Jonathan Taylor

296
Citations
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.

Frauke Muecksch;Yiska Weisblum;Christopher O. Barnes;Fabian Schmidt

282
Citations
Curling of Flap Tips in HIV-1 Protease as a Mechanism for Substrate Entry and Tolerance of Drug Resistance

Walter Robert Peter Scott;Celia A. Schiffer

267
Citations
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia

A Neubauer;RK Dodge;SL George;FR Davey

254
Citations
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors.

Keith P. Romano;Akbar Ali;Cihan Aydin;Djade Soumana

249
Citations
Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia

JD Griffin;R Davis;DA Nelson;FR Davey

248
Citations
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding.

Keith P. Romano;Akbar Ali;William E. Royer;Celia A. Schiffer

234
Citations
How does a symmetric dimer recognize an asymmetric substrate? a substrate complex of HIV-1 protease

Moses Prabu-Jeyabalan;Ellen A. Nalivaika;Celia A. Schiffer

222
Citations
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B.

R O Dillman;R B Davis;M R Green;R B Weiss

218
Citations
Molecular Basis for Drug Resistance in HIV-1 Protease

Akbar Ali;Rajintha M. Bandaranayake;Yufeng Cai;Nancy M. King

181
Citations
Combating susceptibility to drug resistance: lessons from HIV-1 protease.

Nancy M. King;Moses Prabu-Jeyabalan;Ellen A. Nalivaika;Celia A. Schiffer

173
Citations
Viral protease inhibitors.

Jeffrey Anderson;Celia A. Schiffer;Sook-Kyung Lee;Ronald I. Swanstrom

168
Citations
Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A

Michael A. Carpenter;Ming Li;Anurag Rathore;Lela Lackey

162
Citations